Analyses of dosages and blood concentration of cyclosporin A on norrmal Golden Retriever dogs or Golden Retriever with muscular dystrophy
Keywords:Immunosuppression, Golden Retriever muscular dystrophy, Blood concentration, Fluorescence polarization immunoassay (FPIA)
AbstractThe muscular dystrophy of Golden Retriever (GRMD) is a degenerative miopaty caused by the absence of dystrophy and it is genetically homologue of the Duchenne muscular dystrophy in humans, so, these dogs are considerably experimental models for studies on cellular therapy. Their successful depends of the adequate immunosuppression. Cyclosporin A (CsA) is indicated for that and the monitoring of the blood concentration and adverse effects are essential to viabilise the therapy. It was studied GRMD dogs, and normal dogs from the same breed, submitted for therapy with CsA, associated, on GRMD, of cell transplantation. It was evaluated blood concentration of the drug, between two or tree days using the method of FPIA. In our results we found that the CsA blood concentrations oscillated too much on six than eight of our animals. We concluded that the doses varieties individually and the correct dosage as to important as the evaluation of the blood concentration of the drug and became viable for cell therapy.
How to Cite
The journal content is authorized under the Creative Commons BY-NC-SA license (summary of the license: https://